Day 1 - EST/EDT (Eastern Daylight, GMT-4)
Day 1 - EST/EDT (Eastern Daylight, GMT-4)
- Elements that would make a better site-patient experience
- Practical challenges and frustrations from clinical systems
- Sharing positives things that have made the biggest difference
- One thing I wish could be done differently….
- What does the future for sites and patients with integration look like?
- What is driving sponsor interest in eClinical platform integration and what are the concerns?
- Examining the workflow:
- Where does IRT sitting amidst the whole eClinical system data flow?
- Where is it necessary and/or suitable for IRT to integrate?
- Ideal set-up: does all data need to flow through the IRT portal?
- What is appropriate to capture in IRT vs in EDC/eCRF/CDMS systems
- Leveraging APIs to permit single sign on authentication for users
- Centralized data hubs:
- What is it, what are the advantages and how does it work?
- Will a centralized data repository get you submission ready quicker?
- How can smaller companies set up something similar and derive a similar benefit?
- Impact on IRT Professionals - Industry Interactive Poll Time: How many people in the audience have background in IT? How many people oversee more than IRT ie. eConsent; EPro; Forecasting etc
- How is the move towards integration affecting IRT professional development?
- Do IRT folk now need to be experts in other e-clinical systems?
- Practical resources to get equip with information on wider e-clinical systems
- Jason Williams - Senior Manager, Clinical Systems, Takeda
- Joidy Fermin - Associate Director, Clinical Supply Operations, Otsuka
- Natalie Nicholson - Associate Director, Global Clinical Drug Supply Systems, Genmab
- Carly Newhardt - Portfolio Director, YPrime
- Evan Slotter - Associate Product Management Director, IRT, IQVIA Technologies
- Clinical trials today are becoming increasingly complex, and the technology landscape to manage them can be complicated and overwhelming
- What if your platform, founded in the principles of IRT, acted as the central nervous system of your clinical trial, helping you gain control and insight over your complex studies?
- Explore an example of how interoperable systems like eConsent, IRT, and eCOA on a single platform can reduce friction, simplify integrations, keep trials up-to-date, and enable rapid study deployment
- Marc Lisi - Co-founder & Senior Director, Customer Solutions, Suvoda
- Role and rational for IRT and E-Consent and direct to patient system integrations
- Practicalities of delivery: from set-up and delivery to accountability and responsibilities
- Tackling the workflow:
- Identifying which system is the initial point of interaction for patient ID numbers
- Cascade of data and workflow of processes
- Imran Shakur - Director, IRT and Technology Lead, Clinical Supply Management, Alexion
- Chris Driver - Director, IT Architecture, IQVIA
- Whose data is it anyway – site or sponsor? If it’s the site’s data, should all the data be sent to the site?
- Best practice for audit trails
- Practical considerations for end of study data transfers, archival and closure processes
- Derek Thornton - Associate Director, Clinical Systems (IRT), Amgen
- Amy Rupp - Associate Director IRT, CSL Behring
- Craig Mooney - VP, Scientific eTech Enabled Services, Calyx
The landscape of clinical trials has undergone a remarkable transformation with the introduction of eClinical solutions, fundamentally reshaping day-to-day processes from traditional approaches. Automation and the integration of cutting-edge technologies are now the standard for clinical trial teams. However, amidst these advancements, the core requirements and understanding essential for running successful clinical trials remain steadfast. Experience emerges as the primary predictor of success – experience with protocol designs, study team and site expectations, and best standard practices.
Join Kathleen Greenough, an industry veteran with over 20 years of experience, as she delves into the intricate distinctions involved in delivering these sophisticated solutions and why experience is critical. Discover how mastery of these crucial elements can be the key to achieving the successful implementation of technology solutions supporting modern clinical trials. Don't miss this opportunity to explore the perfect blend of cutting-edge technology and invaluable experience that can revolutionize the future of clinical trials.
- Kathleen Greenough - Senior Vice President, Marketing and Commercial Operations, 4G
- Application of AI on RTSM for stock out prediction
- Building an AI predication system for stock out risks – lessons learned
- Performance & Results of the project
- Next steps for the project
- Barry Moore - Head of RTSM, GSK
- Modern Configuration vs. Legacy Customization
- What to consider when evaluating your RTSM providers in 2024
- Scalable Technology driving consistent Quality
- Brian Dunton - Head of Client Services, Atreo.io
- Linda Chan-Kim - Director of Development Systems and Business Informatics, Alumis
The integration of AI into Interactive Response Technology (IRT) has become more than a trend; it's a transformational shift that’s reshaping patient randomization and trial supply management. "Real-world AI in IRT: From ChatGPT to Large Language Models" is structured to guide attendees through a four-step journey: Crawl, Walk, Run, and Fly. This progression offers a comprehensive understanding of how to harness AI from the ground up, focusing on Large Language Models (LLMs).
1. Crawl - Introduction to AI in IRT:
- ChatGPT in Action: Explore the initial steps of AI integration, using ChatGPT to aid in writing specifications and supply predictions
- Demystifying LLMs: An introductory overview of Large Language Models and their potential in IRT
2. Walk - Advanced Techniques with ChatGPT Plus:
- Templates and Automation: Learn how to utilize templates in ChatGPT, streamline repetitive tasks and enhance efficiency
3. Run - Next-Level AI Integration: Advanced Applications:
- Delve into more complex use cases, exploring how advanced AI models can further optimize IRT processes
- Security, Data Strategy, and UX: Address essential technical considerations for success
4. Fly - Enterprise Adoption of LLMs:
- Preparing Your Organization: Strategies to equip your organization for the fullscale adoption of LLMs in the context of IRT/RTSM
- Future Roadmaps: Explore potential and strategic roadmaps for LLMs within the industry
- Attie Heunis - VP Engineering, Endpoint
- Bryan Clayton - Chief Commercial Officer, Endpoint